Mode
Text Size
Log in / Sign up

Alpha-gal syndrome review: delayed reactions, 15,000 new US cases yearlyTick Bite Allergy: 15,000 New Cases Each Year

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider AGS in delayed allergic reactions after mammalian product exposure; refer to allergist and RDN.

This mini-review provides an overview of alpha-gal syndrome (AGS) for clinicians, particularly registered dietitian nutritionists (RDNs), focusing on medical nutrition therapy, education, and counseling. AGS is defined as an IgE-mediated sensitivity to galactose-alpha-1,3-galactose (alpha-gal), a carbohydrate found in mammalian products. The review highlights that reactions are typically delayed, occurring 2–8 hours after exposure, which distinguishes AGS from immediate-type food allergies.

The authors estimate that there are 15,000 new cases of AGS annually in the United States. However, they note that many more cases are suspected due to testing limitations and limited awareness. The clinical spectrum ranges from urticaria to anaphylaxis, with anaphylaxis being a serious adverse event. Sensitization to alpha-gal is most commonly caused by a tick bite, as noted in the review.

A key limitation acknowledged by the authors is the lack of a global estimate of AGS prevalence at this time. This limits the ability to generalize the US incidence to other regions. The review does not report on specific management strategies beyond the role of RDNs, nor does it provide data on treatment efficacy or safety beyond the described adverse events.

For practice, this review underscores the importance of recognizing AGS in patients with delayed allergic reactions after consuming mammalian meat or products. Clinicians should consider AGS in the differential diagnosis and refer patients to appropriate specialists, including allergists and dietitians, for comprehensive management. However, the evidence is based on a narrative synthesis, and further research is needed to establish global prevalence and optimal management protocols.

How this fits prior evidence

This mini-review on alpha-gal syndrome (AGS) adds a new dimension to prior coverage, which focused on oncology treatments. While prior items addressed cetuximab in metastatic colorectal cancer and anal squamous cell carcinoma, this review highlights cetuximab's relevance in AGS: cetuximab contains alpha-gal, and patients with AGS may react to it. The review confirms that AGS is an IgE-mediated sensitivity with delayed reactions, extending the understanding of cetuximab's side-effect profile beyond oncology. It also addresses a gap by providing an overview of AGS for dietitians, which was not covered in prior oncology-focused items. However, the review does not provide comparative data on cetuximab use in AGS patients, so it does not directly contrast with prior findings on cetuximab efficacy.

A recent review explains alpha-gal syndrome (AGS), a food allergy that can develop after a tick bite. The syndrome is an IgE-mediated sensitivity to a sugar molecule called alpha-gal, which is found in red meat and some other products. For people with AGS, eating meat can trigger allergic reactions, but the symptoms are not immediate. Instead, reactions typically occur 2 to 8 hours after exposure, which can make it hard to connect the symptoms to the food.

The review, written for dietitians, notes that AGS is a growing concern in the United States, with an estimated 15,000 new cases each year. However, the true number may be higher because many cases are suspected but not confirmed due to testing limitations and limited awareness among both patients and doctors.

Reactions can range from hives (urticaria) to a severe, life-threatening allergic reaction called anaphylaxis. This is why it is important for people who suspect they have AGS to see an allergist for proper diagnosis and guidance.

The review is a mini-review, meaning it summarizes existing knowledge rather than presenting new research. It does not provide a global estimate of AGS prevalence, and the authors note that more research is needed. For now, the key takeaway is that if you have unexplained allergic reactions hours after eating meat, especially if you've had a tick bite, talk to your doctor.

What this means for you:
Alpha-gal syndrome is a delayed meat allergy from tick bites, with 15,000 new US cases yearly.

Common questions

What is alpha-gal syndrome?

Alpha-gal syndrome (AGS) is an allergy to a sugar molecule called alpha-gal, found in red meat. It is an IgE-mediated sensitivity, meaning the immune system overreacts. The review explains that it is most commonly caused by a tick bite.

How long after eating meat do symptoms start?

Symptoms of alpha-gal syndrome are delayed, typically starting 2 to 8 hours after eating meat or other products containing alpha-gal. This delay can make it hard to link symptoms to food, so it's important to tell your doctor about any tick bites.

How common is alpha-gal syndrome in the United States?

The review estimates that there are about 15,000 new cases of alpha-gal syndrome in the United States each year. However, the actual number may be higher because many cases are not diagnosed due to testing limitations and lack of awareness.

What are the symptoms of an allergic reaction to alpha-gal?

Reactions can range from hives (urticaria) to a severe, life-threatening reaction called anaphylaxis. Because symptoms are delayed, it's important to seek medical help if you experience these after eating meat, especially if you've had a tick bite.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
Alpha-gal syndrome (AGS) is an immunoglobulin E-mediated sensitivity to galactose-alpha-1,3-galactose (“alpha-gal”), an oligosaccharide found in non-primate, mammalian-derived foods and products as well as some plant-based ingredients. Sensitization to alpha-gal is most commonly caused by a tick bite. Once sensitized, individuals experience delayed allergic reactions, typically 2–8 h after exposure to mammalian foods and other alpha-gal containing products. Symptoms range from urticaria to anaphylaxis and differ from exposure to exposure in the same individual, distinguishing AGS from other IgE-mediated food allergies. Recognition of AGS has grown since 2008, when patients receiving the anticancer drug, cetuximab, experienced severe reactions later linked to alpha-gal. In 2009, 24 cases were documented when patients endorsed anaphylaxis and urticaria several hours after eating meat. Today, an estimated 15,000 new cases occur annually in the United States, with many more suspected due to testing limitations and limited awareness among affected individuals and healthcare professionals. AGS has been diagnosed on every continent except Antarctica though there is not a global estimate of AGS prevalence at this time. Given the varying types and severities of sensitivity of this IgE-mediated food allergy, registered dietitian nutritionists (RDNs) are vital members of the care team. This mini review provides an overview of AGS for nutrition professionals that are responsible for delivering medical nutrition therapy, nutrition education, and nutrition counseling across clinical, community, and food service settings.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.